China Universal Asset Management Company’s Charles River Laboratories CRL Stock Holding History

China Universal Asset Management Company’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-89	Closed	-$13.5K	–	486
2025 Q2	$13.5K	Hold	89	–	–	﹤0.01%	461
2025 Q1	$13.4K	Hold	89	–	–	﹤0.01%	468
2024 Q4	$16.4K	Hold	89	–	–	﹤0.01%	488
2024 Q3	$17.5K	Hold	89	–	–	﹤0.01%	408
2024 Q2	$18.4K	Hold	89	–	–	﹤0.01%	393
2024 Q1	$24.1K	Hold	89	–	–	﹤0.01%	424
2023 Q4	$21K	Hold	89	–	–	﹤0.01%	408
2023 Q3	$17.4K	Hold	89	–	–	0.01%	307
2023 Q2	$18.7K	Hold	89	–	–	0.01%	275
2023 Q1	$18K	Hold	89	–	–	0.01%	231
2022 Q4	$19.4K	Sell	89 -11,677	-99%	-$2.55M	0.01%	174
2022 Q3	$2.32M	Buy	11,766 +11,677	+13,120%	+$2.52M	0.97%	39
2022 Q2	$19K	Sell	89 -3,125	-97%	-$764K	0.01%	83
2022 Q1	$913K	Sell	3,214 -5,297	-62%	-$1.63M	0.32%	58
2021 Q4	$3.21M	Buy	+8,511	New	+$3.31M	0.76%	40

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

China Universal Asset Management Company's CRL Position: Q3 2025 in Review

China Universal Asset Management Company sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 89 shares — an estimated $13.5K sold.

China Universal Asset Management Company first reported a position in CRL in Q4 2021 and held it in 15 quarters. The position peaked at $3.21M in Q4 2021. 554 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

China Universal Asset Management Company reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
China Universal Asset Management Company sold 89 Charles River Laboratories shares in Q3 2025, an estimated $13.5K.
China Universal Asset Management Company first reported a position in Charles River Laboratories in Q4 2021 and held it in 15 quarters.
China Universal Asset Management Company's Charles River Laboratories position peaked at $3.21M in Q4 2021.
554 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.